EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors

Conclusion: These results support further investigation into whether EPB41L5 is a biomarker of PNETs with high risk for metastases.

Source: Cancer Genomics and Proteomics - August 28, 2019 Category: Cancer & Oncology Authors: SALLER, J., SEYDAFKAN, S., SHAHID, M., GADARA, M., CIVES, M., ESCHRICH, S. A., BOULWARE, D., STROSBERG, J. R., AEJAZ, N., COPPOLA, D. Tags: Article Source Type: research